Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130
Lobe Sciences Ltd. Announces Exclusive Collaboration With Quality Chemical Laboratories LLC
Quality Chemical Laboratories LLC ("QCL") has developed a synthetic pathway for psilocybin, psilocin and psilocin analogues exclusively for Lobe SciencesQCL agrees to supply Lobe Sciences research and
Lobe Sciences Ltd (LOBEF) Increases Its Portfolio With Several New Chemical Entities (NCEs)
Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023
Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biotechnology company committed to discovering and de
Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and
CSE Bulletin: Consolidation - Lobe Sciences Ltd. (LOBE)
Toronto, Ontario--(Newsfile Corp. - Le 9 juin/June 2022) - Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
New Share Consolidation of Lobe Sciences Ltd., Here's What Changes
Lobe Sciences Ltd. (OTCQB:LOBEF), the Vancouver-based life sciences company focused on developing transformational psychedelic medicines through drug R&A, recently announced the implementation of
Lobe Sciences Ltd. to Webcast Live at VirtualInvestorConferences.com April 27th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.comVANCOUVER, British Columbia, A
Lobe Sciences Ltd. to Participate in the Lytham Partners Spring 2022 Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - March 30, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that it will be participating in the Lytham Par
Lobe Sciences Ltd. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th - 30th from 9:00 A.M. - 5:00 P.M. EDT
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announced today that Philip Young, CEO, has been invited to pr
Lobe Sciences Ltd Invites You to Join Us at the Q1 Virtual Investor Summit
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - Lobe Sciences Ltd (CSE: LOBE) (OTCQB: LOBEF) today announced that Philip Young CEO will be attending the Q1 Virtual Investor Summit.
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program
The Week In Psychedelics Seattle Decriminalizes Psychedelics Along With California City Novamind Launches Program For End-Of-Life And Palliative Care Patients MindMed Teams Up With Sphere Health Form
It is reported that a production line at Tesla, Inc. 's Shanghai factory was partially suspended last month.
A production line at Tesla, Inc. 's Shanghai plant suspended some production last month for about four days due to a lack of key chips, according to people familiar with the matter. The people familiar with the matter spoke on condition of anonymity because the details were kept secret. One of the people familiar with the situation said that the shortage is mainly for the chips needed for the electronic control unit (ECU), a small device that controls one or more electronic systems in the car, a problem that has mainly led to delays in the production of Tesla, Inc. 's Model Y model. At present, production has returned to normal, according to people familiar with the matter. In July, Tesla, Inc. shipped about 33000 electric vehicles in China's domestic and overseas markets.
Morgan Stanley: There are three reasons not to worry about global economic stagnation
Original title: Morgan Stanley: Don't worry about the global economic stagnation. The reason is that three or so years ago, the increase in COVID-19 cases raised concerns about imposing another blockade, while the US delayed passing additional fiscal stimulus measures, which also caused people to worry that there would be problems with the recovery in consumption. According to Morgan Stanley (Morgan Stanley), we are now facing fears that economic growth will be blocked again. But just like last time, this panic will subside. 1. The correlation between the spread of the virus and economic development continues to evolve, and the more infectious Delta variant has led to a rebound in cases, especially among unvaccinated people
Apple is a big deal! Threatened to exit the British market in the face of $7 billion in compensation
Original title: Apple is in big trouble! Apple may face $7 billion in compensation and threaten to withdraw from the UK market Source: FX168 According to a report by the famous technology website AppleInsider on Sunday (July 11), Apple's (Apple) lawyers warned that if the court orders Apple to pay “commercially unacceptable” fees to patent company Optis Cellular for alleged infringement of 3G and 4G patents, the iPhone manufacturer may withdraw from the British market. (Screenshot source: AppleInsider) Apple is currently involved in the UK
Video: Supporting The Green Rush: The Opportunity of Ancillary Cannabis Companies
Video: Supporting The Green Rush: The Opportunity of Ancillary Cannabis Companies
No Data